Assessment of chemotherapy response in colorectal liver metastases in patients undergoing hepatic resection and the correlation to pathologic residual viable tumor

Journal of the American College of Surgeons

Volumn 216, Issue 4, 2013, Pages 845-856

  Egger, Michael E ^a   Cannon, Robert M ^a   Metzger, Tiffany L ^a   Nowacki, Michael ^b   Kelly, Larry ^c   Tatum, Cliff ^c   Scoggins, Charles R ^a   Callender, Glenda G ^a   McMasters, Kelly M ^a   Martin II, Robert C G ^a  

^a University of Louisville School of Medicine   (United States)

^b Norton Cancer Institute   (United States)

^c Norton Healthcare   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ARTICLE; AUTOMATION; CANCER COMBINATION CHEMOTHERAPY; CANCER SIZE; CANCER SURGERY; CLINICAL ARTICLE; COLORECTAL LIVER METASTASIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INDUCTION CHEMOTHERAPY; LIVER FIBROSIS; LIVER RESECTION; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT ASSESSMENT; PREOPERATIVE CARE; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR CELL; TUMOR NECROSIS;

EID: 84875368874     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2012.12.037     Document Type: Article

References (37)

1. R.E. Brown, M.R. Bower, and R.C. Martin Hepatic resection for colorectal liver metastases Surg Clin North Am 90 2010 839 852
2. P.J. Allen, N. Kemeny, and W. Jarnagin Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases J Gastrointest Surg 7 2003 109 115
3. B. Gruenberger, W. Scheithauer, and R. Punzengruber Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases BMC Cancer 8 2008 120
4. R.M. Small, N. Lubezky, and E. Shmueli Response to chemotherapy predicts survival following resection of hepatic colo-rectal metastases in patients treated with neoadjuvant therapy J Surg Oncol 99 2009 93 98
5. Y.S. Chun, J.N. Vauthey, and P. Boonsirikamchai Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases JAMA 302 2009 2338 2344
6. W.S. Chung, M.S. Park, and S.J. Shin Response evaluation in patients with colorectal liver metastases: RECIST version 1.1 versus modified CT criteria AJR Am J Roentgenol 199 2012 809 815
7. J. Shindoh, E.M. Loyer, and S. Kopetz Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases J Clin Oncol 30 2012 4566 4572
8. L. Rubbia-Brandt, E. Giostra, and C. Brezault Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery Ann Oncol 18 2007 299 304
9. D.G. Blazer 3rd, Y. Kishi, and D.M. Maru Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases J Clin Oncol 26 2008 5344 5351
10. M. Klinger, D. Tamandl, and S. Eipeldauer Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX Ann Surg Oncol 17 2010 2059 2065
11. G.A. Poultsides, F. Bao, and E.L. Servais Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome Ann Surg Oncol 19 2012 2797 2804
12. A. Grothey, E.E. Hedrick, and R.D. Mass Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107 J Clin Oncol 26 2008 183 189
13. L.B. Saltz, S. Clarke, and E. Diaz-Rubio Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study J Clin Oncol 26 2008 2013 2019
14. U.P. Neumann, A. Thelen, and C. Rocken Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastases Surgery 146 2009 52 59
15. D.J. Gallagher, J. Zheng, and M. Capanu Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases Ann Surg Oncol 16 2009 1844 1851
16. H. Choi, C. Charnsangavej, and S.C. Faria Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria J Clin Oncol 25 2007 1753 1759
17. R. Lencioni, and J.M. Llovet Modified RECIST (mRECIST) assessment for hepatocellular carcinoma Semin Liver Dis 30 2010 52 60
18. K. Marten, F. Auer, and S. Schmidt Inadequacy of manual measurements compared to automated CT volumetry in assessment of treatment response of pulmonary metastases using RECIST criteria Eur Radiol 16 2006 781 790
19. D.S. Gierada, T.K. Pilgram, and M. Ford Lung cancer: interobserver agreement on interpretation of pulmonary findings at low-dose CT screening Radiology 246 2008 265 272
20. S. Singh, P. Pinsky, and N.S. Fineberg Evaluation of reader variability in the interpretation of follow-up CT scans at lung cancer screening Radiology 259 2011 263 270
21. Borradaile K, Ford R, O'Neal M, Byrne K. Discordance between BICR readers. Applied Clinical Trials Online. Available at: http://www. appliedclinicaltrialsonline.com/appliedclinicaltrials/article/articleDetail.jsp? id=693554. Accessed November 1, 2010.
22. R.C. Martin 2nd, C.R. Scoggins, and D. Tomalty Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trial J Gastrointest Surg 16 2012 1531 1538
23. E.A. Eisenhauer, P. Therasse, and J. Bogaerts New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228 247
24. M.A. Choti, J.V. Sitzmann, and M.F. Tiburi Trends in long-term survival following liver resection for hepatic colorectal metastases Ann Surg 235 2002 759 766
25. B. Nordlinger, M. Guiguet, and J.C. Vaillant Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients Cancer 77 1996 1254 1262
26. T. Mala, G. Bohler, and O. Mathisen Hepatic resection for colorectal metastases: can preoperative scoring predict patient outcome? World J Surg 26 2002 1348 1353
27. M.W. Kattan, M. Gonen, and W.R. Jarnagin A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer Ann Surg 247 2008 282 287
28. R. Adam, E. Avisar, and A. Ariche Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal Ann Surg Oncol 8 2001 347 353
29. T.C. Chua, A. Saxena, and W. Liauw Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases Ann Surg Oncol 17 2010 492 501
30. A. Chiappa, E. Bertani, and M. Makuuchi Neoadjuvant chemotherapy followed by hepatectomy for primarily resectable colorectal cancer liver metastases Hepatogastroenterology 56 2009 829 834
31. L. Vigano, L. Capussotti, and E. Barroso Progression while receiving preoperative chemotherapy should not be an absolute contraindication to liver resection for colorectal metastases Ann Surg Oncol 19 2012 2786 2796
32. J. Edeline, E. Boucher, and Y. Rolland Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma Cancer 118 2012 147 156
33. J.H. Shim, H.C. Lee, and S.O. Kim Which response criteria best help predict survival of patients with hepatocellular carcinoma following chemoembolization? A validation study of old and new models Radiology 262 2012 708 718
34. K. Tanaka, H. Takakura, and K. Takeda Importance of complete pathologic response to prehepatectomy chemotherapy in treating colorectal cancer metastases Ann Surg 250 2009 935 942
35. G. Chan, M. Hassanain, and P. Chaudhury Pathological response grade of colorectal liver metastases treated with neoadjuvant chemotherapy HPB (Oxford) 12 2010 277 284
36. T. Gruenberger, D. Arnold, and L. Rubbia-Brandt Pathologic response to bevacizumab-containing chemotherapy in patients with colorectal liver metastases and its correlation with survival Surg Oncol 21 2012 309 315
37. E. Ramos, C. Valls, and L. Martinez Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Ann Surg Oncol 18 2011 2654 2661